Dr. D. Lansing Taylor, director of the Drug Discovery Institute, is the PI on a $5.8 million grant funded by the National Institutes of Health. The project is a part of the NIH’s Tissue Chip for Drug Screening program, which aims to develop better tools for predicting drug safety and effectiveness.
“Researchers from 11 institutions will collaborate over three years to refine existing 3-D human tissue chips and combine them into an integrated system that can mimic the complex functions of the human body.”
Taylor quotes, “We are very enthusiastic about the potential of these microphysiology systems to serve as powerful platforms for studying human diseases and identifying human toxic liabilities.”
Read more about the project in this article.
University of Pittsburgh receives $5.8M grant to develop 3-D liver model. Pittsburgh, PA 24 Sept 2014. Pittsburgh Post-Gazette.